Effectiveness of Fractionated Rituximab in Preventing Tumor Lysis Syndrome in Aggressive B-Cell Lymphoma: Insights from Real-Life Clinical Practice
Jasmine Mohamad1, Antonin Bouroumeau2, Thomas A. McKee2, Nicolas Mach3, Kaveh Samii4, Martine Chamuleau5, Frank Stenner6, Jerome Tamburini1,2, Noémie Lang1,2
1University of Geneva, Geneva, Switzerland
2Department of Patho-Immunology, Geneva University Medical Centre, Switzerland
3Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland
4Department of Hematology, Hôpitaux Universitaires de Genève, Geneva, Switzerland
5Department Hematology, Cancer Center Amsterdam, Amsterdam UMC, location VU, Amsterdam, Netherlands
6Department Oncology, University Hospital Basel and SAKK, Basel, Switzerland